Cargando…

Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis

Exposure of immunosuppressed individuals to the opportunistic fungal pathogen Aspergillus fumigatus may result in invasive pulmonary aspergillosis (IPA), which can lead to the development of cerebral aspergillosis (CA), a highly lethal infection localized in the central nervous system (CNS). There a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Brianne N., Baggett, Mia A., Guillory, Christa, Jones, MaryJane, Steele, Chad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600342/
https://www.ncbi.nlm.nih.gov/pubmed/36040029
http://dx.doi.org/10.1128/mbio.02254-22
_version_ 1784816818290950144
author Sullivan, Brianne N.
Baggett, Mia A.
Guillory, Christa
Jones, MaryJane
Steele, Chad
author_facet Sullivan, Brianne N.
Baggett, Mia A.
Guillory, Christa
Jones, MaryJane
Steele, Chad
author_sort Sullivan, Brianne N.
collection PubMed
description Exposure of immunosuppressed individuals to the opportunistic fungal pathogen Aspergillus fumigatus may result in invasive pulmonary aspergillosis (IPA), which can lead to the development of cerebral aspergillosis (CA), a highly lethal infection localized in the central nervous system (CNS). There are no experimental models of CA that effectively mimic human disease, resulting in a considerable knowledge gap regarding mechanisms of neurological pathogenicity and neuroimmune responses during infection. In this report, immunosuppressed mice (via acute, high-dose corticosteroid administration) challenged with A. fumigatus resting conidia intranasally, followed a day later by a 70-fold lower inoculum of pre-swollen conidia intravenously (IN + IV + steroid), demonstrated increased weight loss, signs of severe clinical disease, increased fungal burden in the brain, and significant reduction in survival compared to immunosuppressed mice challenged intranasally only (IN + steroid) or non-immunosuppressed mice challenged both intranasally and intravenously (IN + IV). The IN + IV + steroid group demonstrated significant decreases in monocytes, eosinophils, dendritic cells (DCs), and invasive natural killer T (iNKT) cells, but not neutrophils or γδ T cells, in the brain compared to the IN + IV group. Likewise, the IN + IV + steroid group had significantly lower levels of interleukin (IL)-1β, IL-6, IL-17A, CC motif chemokine ligand 3 (CCL3), CXC chemokine ligand 10 (CXCL10), and vascular endothelial growth factor (VEGF) in the brain compared to the IN + IV group. IN + IV + steroid was superior to both IN + IV + chemotherapy (cytarabine + daunorubicin) and IN + IV + neutropenia for the development of CA. In conclusion, we have developed a well-defined, physiologically relevant model of disseminated CA in corticosteroid-induced immunosuppressed mice with a primary pulmonary infection. This model will serve to advance understanding of disease mechanisms, identify immunopathogenic processes, and help define the protective neuroinflammatory response to CA.
format Online
Article
Text
id pubmed-9600342
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-96003422022-10-27 Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis Sullivan, Brianne N. Baggett, Mia A. Guillory, Christa Jones, MaryJane Steele, Chad mBio Research Article Exposure of immunosuppressed individuals to the opportunistic fungal pathogen Aspergillus fumigatus may result in invasive pulmonary aspergillosis (IPA), which can lead to the development of cerebral aspergillosis (CA), a highly lethal infection localized in the central nervous system (CNS). There are no experimental models of CA that effectively mimic human disease, resulting in a considerable knowledge gap regarding mechanisms of neurological pathogenicity and neuroimmune responses during infection. In this report, immunosuppressed mice (via acute, high-dose corticosteroid administration) challenged with A. fumigatus resting conidia intranasally, followed a day later by a 70-fold lower inoculum of pre-swollen conidia intravenously (IN + IV + steroid), demonstrated increased weight loss, signs of severe clinical disease, increased fungal burden in the brain, and significant reduction in survival compared to immunosuppressed mice challenged intranasally only (IN + steroid) or non-immunosuppressed mice challenged both intranasally and intravenously (IN + IV). The IN + IV + steroid group demonstrated significant decreases in monocytes, eosinophils, dendritic cells (DCs), and invasive natural killer T (iNKT) cells, but not neutrophils or γδ T cells, in the brain compared to the IN + IV group. Likewise, the IN + IV + steroid group had significantly lower levels of interleukin (IL)-1β, IL-6, IL-17A, CC motif chemokine ligand 3 (CCL3), CXC chemokine ligand 10 (CXCL10), and vascular endothelial growth factor (VEGF) in the brain compared to the IN + IV group. IN + IV + steroid was superior to both IN + IV + chemotherapy (cytarabine + daunorubicin) and IN + IV + neutropenia for the development of CA. In conclusion, we have developed a well-defined, physiologically relevant model of disseminated CA in corticosteroid-induced immunosuppressed mice with a primary pulmonary infection. This model will serve to advance understanding of disease mechanisms, identify immunopathogenic processes, and help define the protective neuroinflammatory response to CA. American Society for Microbiology 2022-08-30 /pmc/articles/PMC9600342/ /pubmed/36040029 http://dx.doi.org/10.1128/mbio.02254-22 Text en Copyright © 2022 Sullivan et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Sullivan, Brianne N.
Baggett, Mia A.
Guillory, Christa
Jones, MaryJane
Steele, Chad
Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title_full Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title_fullStr Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title_full_unstemmed Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title_short Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis
title_sort neuroimmune responses in a new experimental animal model of cerebral aspergillosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600342/
https://www.ncbi.nlm.nih.gov/pubmed/36040029
http://dx.doi.org/10.1128/mbio.02254-22
work_keys_str_mv AT sullivanbriannen neuroimmuneresponsesinanewexperimentalanimalmodelofcerebralaspergillosis
AT baggettmiaa neuroimmuneresponsesinanewexperimentalanimalmodelofcerebralaspergillosis
AT guillorychrista neuroimmuneresponsesinanewexperimentalanimalmodelofcerebralaspergillosis
AT jonesmaryjane neuroimmuneresponsesinanewexperimentalanimalmodelofcerebralaspergillosis
AT steelechad neuroimmuneresponsesinanewexperimentalanimalmodelofcerebralaspergillosis